Showing results (231-240 of 261) with videos related to

Sort By:
Pageof 27
Nucleic Acids Research|October 8, 2010
Structural basis for the dual RNA-recognition modes of human Tra2-β RRMKengo Tsuda, Tatsuhiko Someya, Kanako Kuwasako, et al.
Clinical Lung Cancer|March 16, 2021
Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine CarcinomaMasayuki Shirasawa, Tatsuya Yoshida, Daisuke Takayanagi, et al.
Protein Science : a Publication of the Protein Society|November 19, 2016
Solution structure of the first RNA recognition motif domain of human spliceosomal protein SF3b49 and its mode of interaction with a SF3b145 fragmentKanako Kuwasako, Nobukazu Nameki, Kengo Tsuda, et al.
Cancer Science|May 11, 2023
Human resources for administrative work to carry out a comprehensive genomic profiling test in JapanHidenori Kage, Katsutoshi Oda, Manabu Muto, et al.
BMC Cancer|May 28, 2017
Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604Yuki Misumi, Hiroaki Okamoto, Jiichiro Sasaki, et al.
Cancers|January 21, 2022
Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 StudyTomoyasu Mimori, Takehito Shukuya, Ryo Ko, et al.
Thoracic Cancer|August 24, 2023
Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non-small cell lung cancer from proteomic profiling of circulating extracellular vesiclesMasahiro Torasawa, Hidehito Horinouchi, Shigehiro Yagishita, et al.
BMJ Open Respiratory Research|January 14, 2021
Utility of radial endobronchial ultrasonography combined with transbronchial lung cryobiopsy in patients with diffuse parenchymal lung diseases: a multicentre prospective studyMinoru Inomata, Naoyuki Kuse, Nobuyasu Awano, et al.
British Journal of Cancer|June 2, 2026
Role of VEGFA/VEGFR2 signaling in predicting clinical outcomes of EGFR-TKI treatment in EGFR-mutant non-small cell lung cancerRyoko Inaba Higashiyama, Tatsuya Yoshida, Kouya Shiraishi, et al.
The Oncologist|March 24, 2018
Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 StudyRyo Ko, Takehito Shukuya, Yusuke Okuma, et al.
Pageof 27